Dendritics SAS appointed Imgenex the exclusive distributor of its monoclonal cell research antibodies in North America and India.

Cell Signaling Technologies is offering a noncommercial, royalty-free license to its PhosphoScan Profiling technology and information from its PhosphoSite knowledgebase to academic and nonprofit institutions.

Exiqon A/S granted Applied Biosystems a license to its Locked Nucleic Acids in siRNA in November 2007.

TriLink Biotechnologies will supply reagents for Applied Biosystems’ SOLiD DNA sequencing system.

Fluorotechnics appointed InterChim as its distribution partner for France and other European countries.

RXi Pharmaceuticals exclusively licensed Invitrogen’s second-generation RNAi technology for designated target genes in all human therapeutic categories.

Funded by a three-year NIH grant of up to $6.8 million, RTI International’s PhenX project will develop consensus measures for phenotypes and exposures.

Peptide provider PolyPeptide Laboratories Group acquired NeoMPS from Isochem in November 2007.

Beckman Coulter acquired the remaining 80.1% of NexGen Diagnostics, a provider of nonseparation immunoassay technology, in November 2007.

SuperArray Bioscience licensed RNAi patents from the Carnegie Institution.

Frontier Scientific acquired assay supplier Echelon Biosciences from Æterna Zentaris in December 2007 for $3.2 million.